The FDA cleared the KRAS-targeted therapy for advanced pancreatic cancer, marking a new treatment paradigm for one of the deadliest cancers and beginning what a

Two unvaccinated Pennsylvania residents died from measles as HHS Secretary Kennedy draws criticism for downplaying the outbreak and spreading vaccine misinforma

The failure erased over $1 billion in market value and cast doubt on the potential of TL1A-blocking drugs for rheumatoid arthritis.

Labcorp and Quest Diagnostics plan to offer the test, which already secured European CE mark certification, potentially expanding access to Alzheimer's screenin

Drugmakers including Novartis, Amgen, and Lilly are racing to develop treatments for elevated Lp(a), a genetic risk factor that currently has no approved therap

Oxford researchers found the shingles shot may be the first vaccine to protect both heart and brain, following earlier data showing reduced dementia risk.

Facing a dwindling cash position after research setbacks, Biohaven agreed to part with its most advanced pipeline asset in what analysts called a surprising tra

Ziihera can now be used as a first-line treatment for all HER2-positive gastroesophageal adenocarcinomas, dramatically widening its market opportunity.

The digital health company's planned acquisition of the meditation and mental health app signals further consolidation in the digital health space.

A real-world analysis indicates Eli Lilly's weight-loss drug Zepbound could lower healthcare utilization, adding to evidence of broader benefits beyond weight l

After a historic dip in biotech jobs in 2025, the Massachusetts sector is recovering this year, though young startups continue to face funding headwinds.

Rising healthcare costs are driving a small but growing share of employers to consider eliminating coverage of GLP-1 weight-loss drugs next year.

Seed and Series A round sizes for Massachusetts biotech startups are diverging, with early-stage companies handling the riskiest science struggling to secure ca

New research shows coronary artery calcium scans help guide statin use in only a small share of borderline-risk patients but can be decisive in those cases.

A STAT analysis examines how Republican-led health funding reductions, mRNA science developments, and Medicaid policy changes are affecting the healthcare lands

After peaking in 2024, VC investment in women's health startups fell last year, though analysts see potential for a recovery driven by AI adoption and an expand

Senators pressed HHS Secretary Kennedy over discrepancies in his disclosures regarding a financial interest in Gardasil litigation.

Researchers argue that framing endometriosis, osteoporosis, and autoimmune treatments in terms of financial returns could attract more investment into women's h